1. Is Metropolis Healthcare Ltd a good quality company?
Past 10 year's financial track record analysis by Moneyworks4me indicates that Metropolis Healthcare Ltd is a good quality company.
2. Is Metropolis Healthcare Ltd undervalued or overvalued?
The key valuation ratios of Metropolis Healthcare Ltd's currently when compared to its past seem to suggest it is in the Fair zone.
3. Is Metropolis Healthcare Ltd a good buy now?
The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Metropolis Healthcare Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
Value Creation ⓘValue Creation Index Colour Code Guide ⓘ
|ROCE % ⓘ||0%||0%||0%||15.7%||23.4%||31%||27.4%||28.6%||28.3%||31.2%||-|
|Value Creation Index ⓘ||NA||NA||NA||0.2||0.7||1.3||1.0||1.0||1.1||1.3||-|
Growth Parameters ⓘGrowth Parameters Colour Code Guide ⓘ
|YoY Gr. Rt. %||-||NA||NA||NA||15.2%||4%||18.8%||17.6%||12.5%||16.5%||-|
|Adj EPS ⓘ||0||0||0||61.8||83.3||102||108.5||24.1||25.2||36.1||49.5|
|YoY Gr. Rt. %||-||NA||NA||NA||34.9%||22.5%||6.4%||-77.8%||4.3%||43.5%||-|
|BVPS (₹) ⓘ||0||0||0||366.3||277.7||338.6||432.8||82.9||103||136.6||165.1|
|Adj Net Profit ⓘ||0||0||0||60.9||79.5||97.4||104||121||127||185||253|
|Cash Flow from Ops. ⓘ||0||0||0||69.7||88.2||102||104||90.2||215||249||-|
|Debt/CF from Ops. ⓘ||0||0||0||0.2||0.1||0||0||0.2||0||0||-|
CAGR ⓘCAGR Colour Code Guide ⓘ
|9 Years||5 Years||3 Years||1 Years|
|Adj EPS ⓘ||NA||-15.4%||-30.7%||43.5%|
Key Financial Parameters ⓘPerformance Ratio Colour Code Guide ⓘ
|Return on Equity % ⓘ||0||0||0||16.9||25.4||33.1||28.1||29.1||27||30||32.8|
|Op. Profit Mgn % ⓘ||0||0||0||25.9||26.2||28.4||28||27||27.8||29.3||31.4|
|Net Profit Mgn % ⓘ||0||0||0||14.9||16.8||18.9||17.2||16.5||15||18.5||21.2|
|Debt to Equity ⓘ||0||0||0||0||0||0||0||0||0||0||0|
|Working Cap Days ⓘ||0||0||0||0||82||82||160||218||187||127||226|
|Cash Conv. Cycle ⓘ||0||0||0||0||22||18||23||33||18||-9||161|
Return on Equity has increased versus last 3 years average to 32.80%
Sales growth is growing at healthy rate in last 3 years 15.53%
Sales growth is good in last 4 quarters at 49.38%
Net Profit has been subdued in last 3 years -30.71%
|TTM EPS (₹)||48.3||49.5|
|TTM Sales (₹ Cr.)||969||1,196|
|BVPS (₹.) ⓘ||160.2||165.1|
|Reserves (₹ Cr.) ⓘ||809||835|
|From the Market|
|52 Week Low / High (₹)||1846.50 / 3579.00|
|All Time Low / High (₹)||904.85 / 3579.00|
|Market Cap (₹ Cr.)||13,003|
|Equity (₹ Cr.)||10.2|
|Face Value (₹)||2|
|Industry PE ⓘ||75.4|
Metropolis Healthcare Limited is one of leading and renowned Indian diagnostics companies. The company owns a chain of diagnostic ce9ntres across India, South Asia, Africa and the Middle East. Over the years, Metropolis has carved a niche for itself. The company enjoys a loyal customer base, reflecting its strength as a brand offering superior diagnostic tests and services.
With its widespread operational network, Metropolis offers a comprehensive range of clinical laboratory tests and profiles. These tests and profiles are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease. Metropolis plays a pivotal role in raising the bar of diagnostic accuracy, technological equipment, customer experience and research-driven empathetic service in the industry.
Business area of the company
Metropolis Healthcare is engaged in the business of providing pathology and related healthcare services. The profile comprises of a variety of test combinations which are specific to a disease or disorder as well as wellness profiles that are used for health and fitness screening. It classifies its tests into ‘routine’ tests such as blood chemistry analyses, blood cell counts and urine examination; ‘semi-specialized’ tests such as thyroid function tests, viral and bacterial cultures, histology, cytology and infectious disease tests; and ‘specialized’ tests such as tests for coagulation studies, autoimmunity tests, cytogenetics and molecular diagnostics. It is focused on providing reliable test results as well as value-added services such as home collection of specimens and online access to test reports. It also offers customized wellness packages to its institutional customers as per their requirement.
Major Events & Milestones